Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 2.020
0.00 (0.00%)
Sep 29, 2025, 11:30 AM CST
Kangmei Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 9.71 | 8.57 | 102.52 | -2,688 | 7,918 | -31,085 | Upgrade |
Depreciation & Amortization | 318.05 | 334.57 | 346.18 | 365.69 | 603.22 | 644.83 | Upgrade |
Other Amortization | 41.44 | 38.83 | 22.49 | 27.73 | 35.19 | 133.15 | Upgrade |
Loss (Gain) From Sale of Assets | -11.39 | -39.47 | -19.61 | -0.98 | -64.01 | 44.96 | Upgrade |
Asset Writedown & Restructuring Costs | 31.81 | 31.47 | 99.97 | 307.46 | 2,643 | 1,508 | Upgrade |
Loss (Gain) From Sale of Investments | -17.62 | -59.18 | -44.4 | -0.75 | -188.79 | 4.59 | Upgrade |
Provision & Write-off of Bad Debts | 62.36 | 24.89 | -238.47 | 213.41 | 1,192 | 1,003 | Upgrade |
Other Operating Activities | 81.04 | 114.76 | 196.51 | 278.14 | 2,577 | 26,027 | Upgrade |
Change in Accounts Receivable | -522.24 | -502.64 | 215.15 | -339.53 | -746.88 | 3,130 | Upgrade |
Change in Inventory | 278.23 | -34.32 | -93.01 | -253.62 | 1,666 | 1,912 | Upgrade |
Change in Accounts Payable | -469.98 | -347.41 | -896.42 | 1,321 | -15,587 | -2,298 | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | 0.59 | -8.93 | Upgrade |
Operating Cash Flow | -190.89 | -427.63 | -317.52 | -749.96 | 214.21 | 1,031 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | -79.23% | -64.21% | Upgrade |
Capital Expenditures | -60.68 | -61.71 | -99.74 | -48.12 | -171.63 | -301.73 | Upgrade |
Sale of Property, Plant & Equipment | 125.6 | 164.33 | 52.25 | 1.55 | 77.9 | 1,135 | Upgrade |
Divestitures | 19.8 | 27.3 | 9.85 | - | 57.72 | -0.74 | Upgrade |
Investment in Securities | - | - | - | - | -0.53 | - | Upgrade |
Other Investing Activities | 10 | 10 | - | 0.55 | 0.04 | - | Upgrade |
Investing Cash Flow | 94.72 | 139.92 | -37.64 | -46.02 | -36.51 | 832.06 | Upgrade |
Short-Term Debt Issued | - | - | - | - | 127.64 | - | Upgrade |
Long-Term Debt Issued | - | 0.1 | - | - | - | 10,572 | Upgrade |
Total Debt Issued | 0.1 | 0.1 | - | - | 127.64 | 10,572 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -97.03 | - | Upgrade |
Long-Term Debt Repaid | - | -54.46 | -72.71 | -94.95 | -48.66 | -11,419 | Upgrade |
Total Debt Repaid | -51.28 | -54.46 | -72.71 | -94.95 | -145.69 | -11,419 | Upgrade |
Net Debt Issued (Repaid) | -51.18 | -54.36 | -72.71 | -94.95 | -18.05 | -847.07 | Upgrade |
Issuance of Common Stock | 1.15 | 1.15 | - | - | 1,800 | - | Upgrade |
Common Dividends Paid | -0.75 | -0.75 | - | -0.9 | -13.82 | -1,032 | Upgrade |
Dividends Paid | -0.75 | -0.75 | - | -0.9 | -13.82 | -1,032 | Upgrade |
Other Financing Activities | 302.03 | 228.78 | -48.14 | -21.01 | 0.25 | 2.77 | Upgrade |
Financing Cash Flow | 251.24 | 174.81 | -120.85 | -116.86 | 1,768 | -1,876 | Upgrade |
Foreign Exchange Rate Adjustments | - | -0 | 0 | 0 | -0.04 | -0.25 | Upgrade |
Net Cash Flow | 155.08 | -112.91 | -476.01 | -912.84 | 1,946 | -13.13 | Upgrade |
Free Cash Flow | -251.57 | -489.34 | -417.27 | -798.08 | 42.58 | 729.67 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -94.16% | -69.71% | Upgrade |
Free Cash Flow Margin | -4.75% | -9.43% | -8.56% | -19.09% | 1.03% | 13.48% | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.03 | -0.04 | -0.06 | 0.00 | 0.05 | Upgrade |
Cash Interest Paid | - | - | - | 1.06 | - | - | Upgrade |
Cash Income Tax Paid | 147.8 | 295.28 | 211.36 | 284.45 | 235.31 | 295.57 | Upgrade |
Levered Free Cash Flow | 1,325 | -313.1 | 1,126 | 117.24 | -6,029 | 21,968 | Upgrade |
Unlevered Free Cash Flow | 1,336 | -299.73 | 1,161 | 166.55 | -5,391 | 23,320 | Upgrade |
Change in Working Capital | -706.28 | -882.08 | -782.71 | 747.5 | -14,501 | 2,751 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.